Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;12(5):783-791.
doi: 10.4168/aair.2020.12.5.783.

Management of Allergic Patients During the COVID-19 Pandemic in Asia

Jae Hyun Lee  1 , Youngsoo Lee  2 , Suh Young Lee  3 , Hugo Van Bever  4 , Hongfei Lou  5   6 , Luo Zhang  5   6   7 , Hae Sim Park  8
Affiliations
Review

Management of Allergic Patients During the COVID-19 Pandemic in Asia

Jae Hyun Lee et al. Allergy Asthma Immunol Res. 2020 Sep.

Abstract

Although a viral infection is a major triggering factor of asthma and allergic diseases, asthma is suggested to be not a predisposing condition for coronavirus disease 2019 (COVID-19) infection. However, patients with severe asthma/allergic disease requiring systemic corticosteroids or immunosuppressive agents may be at higher risk of more severe clinical course of this infectious disease. For allergic patients who have been followed up at an allergy clinic in our region, it is recommended that they (patients with asthma, rhinitis, atopic dermatitis or chronic urticaria) continue to receive maintenance therapy and be in a well-controlled status. Patients who have used biologics (currently available for targeting type 2 inflammation) and allergen immunotherapy should continue the treatment while minimizing hospital and face-to-face visits. It is essential to wear protective equipment for the protection of health care workers as well as patients. We report this consensus to support allergists and clinical immunologists to make optimal decisions under the urgent situation in Asia.

Keywords: Asia; Coronavirus; allergy and immunology; asthma; atopic dermatitis; chronic urticaria; immunotherapy; management; pandemics; rhinitis.

PubMed Disclaimer

Conflict of interest statement

There are no financial or other issues that might lead to conflict of interest

References

    1. del Rio C, Malani PN. COVID-19-new insight on a rapidly changing epidemic. JAMA. 2020;323:1339–1340. - PubMed
    1. World Health Organization. WHO COVID-19 dashboard [Internet] Geneva: WHO; 2020. [cited 2020 May 25]. Available from: https://covid19.who.int/
    1. Korean Society of Infectious Diseases; Korean Society of Pediatric Infectious Diseases; Korean Society of Epidemiology; Korean Society for Antimicrobial Therapy; Korean Society for Healthcare-associated Infection Control and Prevention; Korea Centers for Disease Control and Prevention. Report on the epidemiological feature of coronavirus disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci. 2020;35:e112. - PMC - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and important lesson from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. - PubMed
    1. Park SY, Kim JH, Kim HJ, Seo B, Kwon OY, Chang HS, et al. High prevalence of asthma in elderly women: findings from a Korean national health database and adult asthma cohort. Allergy Asthma Immunol Res. 2018;10:387–396. - PMC - PubMed